Study Reveals Semaglutide May Reduce Opioid Overdose Risk in Patients With Type 2 Diabetes and Opioid Use Disorder A groundbreaking study published in JAMA Network Open explores the potential benefits
Author: Cody Micah Carmichael MPH, CPH
Top 5 Takeaways Increasing HIV Diagnoses: The number of HIV diagnoses among persons who inject drugs (PWID) in Kanawha County rose significantly from less than five annually during 2016–2018 to
Top 5 Takeaways Significant Reduction in HIV Diagnoses: New HIV diagnoses among adolescent girls and young women attending antenatal care decreased by 71.4% in DREAMS districts compared to 48.4% in
Top 5 Takeaways High Vaccine Effectiveness: The Pfizer-BioNTech vaccine showed a 91% effectiveness against MIS-C in persons aged 12–18 years. Critical Illness Prevention: All critically ill MIS-C patients requiring life
Top 5 Takeaways Continued Benefits of Mandated Reporting: Mandated NAS case reporting helps quantify NAS incidence and guides state program development. Challenges in Long-Term Surveillance: Persistent data collection challenges and
Top 5 Takeaways Overall Decrease in Incidence: Breast cancer incidence among women aged ≥20 years decreased an average of 0.3% per year from 1999 to 2018. Racial and Ethnic Variations:
Top 5 Takeaways Disparities in Monoclonal Antibody Treatment: Black, Asian, and Hispanic patients received monoclonal antibody (mAb) treatments significantly less often than White and non-Hispanic patients. Inpatient Treatment Differences: Disparities
Epi Explained: Understanding Incidence Rate In epidemiology, the incidence rate is one of the most important measures for understanding the occurrence of new cases of a disease or condition over
Epi Explained: What are Sensitivity and Specificity in Epidemiology? Quick Takeaways Sensitivity measures a test’s ability to correctly identify individuals with the disease. Specificity measures how well a test correctly
Top 5 Takeaways Preferential Recommendation: The Advisory Committee on Immunization Practices (ACIP) now recommends mRNA COVID-19 vaccines over the Janssen vaccine for all persons aged ≥18 years. Safety Concerns: Cases